News

Stay ahead of the health curve as we cover and analyze the facts, and debunk the myths in the latest news and trending topics on health and obesity.

How does Oforglipron compare?

Orforglipron, Semaglutide, and Danuglipron are oral GLP-1 agonists that are all similar enough that cost may end up being the winning factor.

Eli Lilly’s retatrutide has shown stronger weight loss effects than others we’ve seen so far. However, it may have additional heart risks.

The current evidence suggests that GLP-1 agonists do not cause suicidal thoughts. In fact, they may actually be beneficial for depression.

Pfizer’s danuglipron may give Ozempic a run for its money, however has not proven itself to be as effective as Wegovy for weight loss.

The shortage of Ozempic has led to many compounding pharmacies using a knock-off version of semaglutide that has not been FDA approved.

A migraine medication called frovatriptan has shown some potential for weight loss by stimulating serotonin receptors that suppress appetite.

Exercise produces many beneficial chemicals in your body, one of which has been recently isolated called N-lactoyl-phenylalanine (Lac-Phe).

The timing of when you eat can affect the health of your gut microflora, something that plays a large role in metabolic health and obesity.

Preliminary studies show Mounjaro (tirzepatide) to be more effective and have less side effects than Wegovy (semaglutide).

It would be very difficult for Mike Pompeo to naturally lose 90 pounds in 6 months himself, without the help of medical interventions.